Panton-Valentine leukocidine (PVL) is a distinctive virulence factor of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), and arginine catabolic mobile element (ACME) is a staphylococcal genomic island that enhances fitness and the ability of bacterial cells to colonize on skin and mucous membranes. ACME is characteristically found in USA300, which is a predominant CA-MRSA clone [sequence type (ST) 8] in the USA and is spreading globally, and has also been detected in non-ST8 MRSA at low frequency. In Japan, spread of MRSA with PVL and/or ACME and their genetic traits have not yet been well characterized. In the present study, the prevalence and genetic diversity of PVL + /ACME + MRSA were investigated for 422
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MRSA clinical isolates collected from outpatients in northern Japan over a period of 1 year. All the isolates were genotyped for the staphylococcal cassette chromosome mec (SCCmec) and coagulase genes (coa), and screened for PVL and ACME genes. The PVL + /ACME + isolates were studied further by genetic analysis, including single-nucleotide polymorphism (SNP) analysis based on PVL genes (lukS-PV-lukF-PV), ACME (arc and opp3 clusters) and the sarU promoter region. Among all the isolates examined, PVL genes and ACME were detected in eight (SCCmec-II, n51; SCCmec-IV, n56; SCCmec-V, n51) and 20 (SCCmec-II, n514; SCCmec-IV, n55; SCCmec-V, n51) isolates, respectively. Five isolates were found to have both PVL genes and ACME (type I), and were classified into ST8/spa-t008/agr-I/coa-IIIa, which is the same genetic traits as USA300. Fifteen PVL " /ACME + isolates had type DII-ACME, belonging to either ST5 or ST764 [clonal complex (CC) 5], and spa-t001, -t002 or -t3557. All the ST8 PVL + /ACME-I
INTRODUCTION
Staphylococcus aureus, particularly meticillin-resistant S. aureus (MRSA), is one of the most important pathogens of nosocomial infections as well as community-acquired infections. Since the 1990s, infections due to communityassociated MRSA (CA-MRSA) have emerged as a public health threat worldwide (David & Daum, 2010; DeLeo et al., 2010) . CA-MRSA has been linked to carriage of PantonValentine leukocidine (PVL), a two-component leukolytic toxin (Robinson et al., 2005; Vandenesch et al., 2003) , and has been identified in a variety of community populations, associated with skin and soft tissue infections, as well as more severe symptoms in a wide spectrum of infections (Baba et al., 2002; Francis et al., 2005) . Recently, CA-MRSA strains harbouring the PVL-encoding lukS-PV and lukF-PV genes have been found increasingly, both in healthy individuals in the community and in hospitalized patients (Hetem et al., 2012; Yamamoto et al., 2010) . Furthermore, although hospital-associated (HA)-MRSA strains are rarely transmitted in the community, CA-MRSA strains have begun to be transmitted within healthcare facilities (D'Agata et al., 2009; Hetem et al., 2012) .
USA300 is known as a predominant CA-MRSA clone in the USA, acquiring resistance to more antimicrobial agents, and is spreading globally and is recognized as a dominant CA-MRSA strain in several countries (Mediavillaet al., 2012; Nimmo, 2012; O'Hara et al., 2012; Tenover & Goering, 2009 ). More recent studies have revealed that this strain is also becoming a common cause of MRSA infections in healthcare facilities (Lessa et al., 2012; Sanchini et al., 2013) . USA300-0114, a variant (a pulsed-field gel electrophoresis subtype) of USA300, has been dominant in CA-MRSA epidemics in the USA (Tenover et al., 2006) , and belongs to multilocus sequence type (ST) 8 grouped into clonal complex (CC) 8, and spa type t008 (spa-t008), and is characterized by the presence of staphylococcal cassette chromosome mec type IVa (SCCmec-IVa) and PVL genes in WSA2USA, and arginine catabolic mobile element (ACME), which is a genetic island integrated into orfX, located adjacent to SCCmec (Diep et al., 2006 (Diep et al., , 2008 . ACME is frequently found in coagulase-negative staphylococcal species (Barbier et al., 2011; Diep et al., 2006) and enhances fitness and the ability to colonize skin and mucous membranes, and is thus considered a key factor in the persistence of USA300 in the community . ACME identified in the USA300 clone (type I) is a 30.9 kb DNA element that contains two main gene clusters, i.e. the arc cluster (argR, arcA, arcD, arcB and arcC) and opp3 cluster (opp-3A, opp-3B, opp-3C, opp-3D and opp-3E), associated with copA encoding a copper-transporting ATPase located near the opp3 cluster (Diep et al., 2006) . However, some genetic variants of ACME have also been reported. Type II ACME (ACME-II) identified in Staphylococcus epidermidis (Diep et al., 2006) lacks the opp3 gene cluster, and ACME-DII found in ST22-MRSAIVh lacks both the opp3 gene cluster and copA. In Japan, despite low prevalence, USA300-like MRSA has been detected sporadically in several locations since 2007 (Higashiyama et al., 2010; Higuchi et al., 2010; Nagao et al., 2010; Shibuya et al., 2008) . In our previous study in Hokkaido, the northern main island of Japan, two PVL + / ACME-I + ST8 MRSA isolates were first detected in 2009 and 2010 among 1366 clinical isolates from a university hospital (Kawaguchiya et al., 2013) . In the study, ACME-DII + , PVL 2 ST5 MRSA was also identified, although the presence of ACME in non-ST8 MRSA has been extremely rare. These findings suggested the emergence and potential spread of ACME + MRSA including USA300-like ST8 strains in northern Japan. The aim of the present study was to investigate the prevalence and genetic characteristics of PVL + /ACME + MRSA strains among community-associated isolates in northern Japan. In particular, to understand the genetic evolution and spread from the USA300 clone, the genetic diversity of these isolates was studied by genotyping, profiling of virulence/resistance factors, and single-nucleotide polymorphism (SNP) analysis of PVL genes, ACME and the sarU promoter regions.
METHODS
Bacterial isolates and molecular typing. A total of 422 clinical isolates of MRSA were analysed. These isolates were collected from outpatients who visited various hospitals and clinics in Hokkaido, Japan, from January to December 2011. Bacterial isolation from clinical specimens and species identification were carried out in the Sapporo Clinical Laboratory, Sapporo, Japan. Only one isolate per patient was used as a study subject. For all isolates, the presence of the staphylococcal 16S rRNA gene, nuc, mecA, PVL-encoding lukS-PV and lukF-PV genes and ACME arcA (arginine deiminase gene) was investigated by multiplex PCR assay as described by Zhang et al. (2008) . SCCmec typing (Kondo et al., 2007) and subtyping (Iwao et al., 2012a, b; Milheiriço et al., 2007) , and coagulase gene (coa) typing (Hirose et al., 2010) were also performed by multiplex PCR using previously published primers and conditions. Antimicrobial susceptibility testing, detection of genes associated with virulence and drug resistance genes. For representative isolates including those with PVL and/or ACME, MICs for 14 antimicrobial agents (oxacillin, ampicillin, cefoxitin, vancomycin, gentamicin, kanamycin, fosfomycin, tetracycline, minocycline, ciprofloxacin, clindamycin, erythromycin, cefaclor and cefazidime) were measured using a broth microdilution test. Susceptibility to linezolid and imipenem was evaluated by E-test (bioMérieux). Breakpoints defined in the Clinical Laboratory Standards Institute guidelines (CLSI, 2012) were used to distinguish between resistant and susceptible strains. For the above selected isolates, multilocus sequence typing (Enright et al., 2000) , spa gene typing (Shopsin et al., 1999) and agr gene typing (Strommenger et al., 2004) were performed as described previously. Multiplex or monoplex PCR was used to screen the presence of genes encoding enterotoxins and other toxins, exoenzymes, adhesins, regulatory elements and antimicrobial resistance genes using primers described previously (Aung et al., 2011; Cassat et al., 2005; Kawaguchiya et al., 2011; Otsuka et al., 2006; Shore et al., 2010; van Wamel et al., 2006) and those designed in the present study (Table S1 , available in JMM Online). ACME typing and identification of PVL phages. ACME types I, II and DII were classified by long-range-PCR (LR-PCR), in terms of orientation and size of the ACME-arcA locus (LR-PCR 1), the region between ACME-arc and ACME-opp3 (LR-PCR 2) and the region between ACME-opp3 and the copA junction (LR-PCR 3), as described previously (Barbier et al., 2011; Kawaguchiya et al., 2013) . PVLencoding phages for all PVL-positive isolates were determined by multiplex PCR, as described previously (Boakes et al., 2011; Ma et al., 2008) .
SNPs in PVL, ACME and the sarU promoter region. To investigate the genetic diversity of PVL + and/or ACME + isolates, SNPs in PVL genes (lukS-PV, lukF-PV) (1918 bp), both arc (6174 bp) and opp3 (2950 bp) clusters of ACME and the sarU promoter region were analysed by PCR and direct sequencing, using primers designed in the present study based on the two complete genome sequences [GenBank accession nos CP000255 and CP000730 for USA300 strain FPR3757 (Diep et al., 2006) and USA300 strain TCH1516 (Highlander et al., 2007) , respectively] (Table S1 ). Primers used for sequencing of the sarU promoter region have been described previously (Kawaguchiya et al., 2013) .
RESULTS
Among the 422 MRSA isolates analysed in this study, the dominant SCCmec type was type II (SCCmec-II; 74.2 %), followed by SCCmec-IV (12.1 %), I (5.5 %) and SCCmec-V (5.0 %) ( Table 1 ). The SCCmec-II isolates were mostly classified into coagulase genotype coa-IIa (91.1 %, 285/ 313), whilst SCCmec-IV isolates were assigned to other types, with coa-IIIa being the most frequent (64.7 %, 33/ 51). The PVL gene was detected in eight isolates with SCCmec-IV (six isolates) and SCCmec-II or SCCmec-V (one isolate each). ACME-arcA was detected in 20 isolates, among which the PVL gene was positive in five SCCmec-IV isolates, whilst most of PVL 2 isolates were SCCmec-II.
Further genetic traits as well as antimicrobial susceptibility were characterized for all 23 PVL + and/or ACME + MRSA isolates and eight PVL 2 /ACME 2 MRSA isolates with SCCmec-II, SCCmec-IV and SCCmec-V (Tables 2 and 3) . ACMEs of PVL + /ACME + isolates were assigned to type I, whilst those of PVL 2 /ACME + isolates were assigned to type DII. All five PVL + /ACME + MRSA, which had subtype SCCmec-IVa, were derived from abscess (n54) or otorrhoea (n51), and belonged to ST8 (CC8), spa-t008, agr type I (agr-I) and coa-IIIa. All the ST8 isolates were positive for sek and seq, and for sak (staphylokinase) and chp (chemotaxis-inhibiting protein), but lacked scn (staphylococcal complement inhibitor). Although the profile of virulence-associated factors was identical among the five ST8 isolates, aph(39)-III and tet(K) were harboured by four and two isolates, respectively. Whilst these isolates exhibited similar resistance patterns, resistance to tetracycline and kanamycin was dependent on the presence of tet(K) and aph(39)-III, respectively.
Three PVL + /ACME 2 isolates had different SCCmec types (II, IVc and V), and belonged to ST772 (CC1; one isolate) or ST30 (CC30; two isolates), which were associated with spa-t11587 or -t019, agr-II or -III, and coa-VIa or -IVa, respectively, showing two different profiles of virulence factors and resistance genes. Regulatory factors sarT, sarU DThe following genes were undetectable in any strains: lukM, sed, see, seh, ses, set, eta, etd and edin-B. dNo gene was detected except for those described in footnote *. Diversity of PVL/ACME-positive MRSA in northern Japan and rap and the GntR family regulatory gene were not detected in the two ST30 isolates, nor in the PVL 2 /ACME 2 isolate SC98.
The 15 PVL 2 /ACME + isolates were derived from eye, ear and respiratory or urinary tract. These isolates were classified into either ST5 (three isolates) or ST764 (CC5, a single locus variant of ST5; 12 isolates), spa-t001, -t002 or -t3557, agr-II and coa-IIa. These isolates had more resistance genes to aminoglycoside, macrolide and tetracycline, showing resistance to more antimicrobials than PVL + and PVL 2 /ACME 2 isolates, although none of the isolates possessed tet(K) and msrA. Among the PVL 2 / ACME + isolates, four and two profiles of enterotoxins and adhesins were observed, and three different patterns were found in the presence of sak, chp and scn. All the CC5 MRSA isolates had the enterotoxin gene cluster (seg-seisem-sen-seo-seu). One of the three ST5 ACME + isolates (SC290) had seb, sek, seq and sep in SaPI3, whilst the other two isolates (SC122 and SC304) possessed tsst-1, sec and sel carried by SaPIbov1. Most of CC5 ACME + isolates, as well as five ST8 PVL + /ACME + isolates, harboured fnbA, ebpS, icaA, sdrC and sdrE, although two ST5 ACME + isolates did not harbour sdrE, instead having sec and tsst-1. Among the PVL 2 /ACME 2 isolates examined, one isolate (SC425) was found to possess a novel subtype of SCCmec IV (IVl) (Iwao et al., 2012b) .
All 31 isolates analysed were resistant to oxacillin, ampicillin, cefoxitin, clindamycin, cefaclor and cefazidime, and susceptible to vancomycin and linezolid, although ST8 PVL + isolates exhibited lower MICs to oxacillin (¡64 mg l
21
) than CC5 isolates (¢512 mg l 21 ) (data not shown).
Phage typing and SNP analysis of the PVL genes (lukS-PV, lukF-PV) indicated that the five PVL + /ACME + isolates possessed WSA2USA containing PVL genes of haplotype R1, which is identical to that of USA300-0114-FPR3757 and -TCH1516 (Baba et al., 2002; Brown et al., 2012) (Table 4 ). In contrast, PVL genes of the three PVL + / ACME 2 isolates were assigned to haplotype H2 or H3, and found to be located in different phages from that of USA300 strains. SNPs in the arc cluster in ACME were analysed for the five ST8 isolates, three representative ST5 isolates and three isolates selected from the 12 ST764 isolates. This analysis indicated the presence of seven haplotypes (AC1-AC7) among the 11 ACME + MRSA isolated in the present study, two isolates in our previous study (SR141 and SR388; Urushibara et al., 2012) and previously reported five strains (USA300, M1, Bartels et al., 2011; M08/0126, Shore et al., 2011; Sa0059, Espedido et al., 2012; NN54, Takano et al., 2013 ; S. epidermidis strain ATCC 12228, Zhang et al., 2003) , in terms of nucleotide difference at 11 sites scattered throughout the arc cluster (Table 5) . Haplotypes AC1 and AC2 were assigned to the arc cluster of USA300 and ATCC 12228, representing ACME-I and -II, respectively. The other five types, AC3-AC7, were allocated to 12 isolates with ACME-DII, based on nucleotide difference at three sites in arcB and arcD. 
*ACME-arcA clusters identified in this study were compared with the following publicly available staphylococcal genomic sequences: USA 300 (USA 300-FPR3757 and USA-TCH1516); S. epidermidis strain ATCC12228 (GenBank accession no. AE0159229); S. aureus strains M08/0126 (FR753166), M1 (HM030720), Sa0059 (JQ412578). NN54 (AB687558), SR388 (AB665981), SR141 (AB665980). These reference strains are shown in bold type. DACME type: I, arcA Diversity of PVL/ACME-positive MRSA in northern Japan
The five ST8 MRSA had an arc cluster of AC1, the identical haplotype to that of USA300, and also possessed an opp3 cluster with identical sequences to USA300 (data not shown). Between AC1 and the other haplotypes, nine to 11 nucleotide differences, which included four positions causing amino acid changes, were found. Similarly, six to eight nucleotide differences were detected between AC2 and AC3-AC7. However, only one to three nucleotide differences were different among haplotypes AC3-AC7, which were found in isolates with ACME-DII. The most frequent haplotype among ACME-DII MRSA was AC5, which is a single-nucleotide variant of AC3 allocated to the strain M08/0126.
The sarU promoter sequence has been described as a divergent region that discriminates USA300-TCH1516 from USA300-FPR3757 by a 4 nt deletion (Highlander et al., 2007) . Compared with the sarU promoter region in USA300-FPR3757 (Fig. S1 ), the ST8 PVL + /ACME-I + MRSA detected in the present study lacked 2 nt. In contrast, a 6 nt deletion was detected in ST5 and ST764 PVL 2 /ACME-DII + MRSA isolates.
DISCUSSION
Although detection of USA300 (ST8-CA-MRSA-IV) strains has been documented in several studies in Japan (Higashiyama et al., 2010; Higuchi et al., 2010; Iwao et al., 2012a; Kawaguchiya et al., 2013; Mine et al., 2011; Nagao et al., 2010; Shibuya et al., 2008; , strains with genotype ST8/spa-t008/agr-I/SCCmec-IVa typical of USA300-0114 have been identified in only a few reports (Higashiyama et al., 2010; Mine et al., 2011; Nagao et al., 2010; Shibuya et al., 2008) , including our previous hospital-based study from 2008 to 2010 in Hokkaido, the northern main island of Japan (Kawaguchiya et al., 2013) . In our present study, five USA300-0114-like MRSA were isolated from sporadic and unrelated outpatients over a period of 1 year (2011). Thus, it was considered that MRSA with the USA300-0114 genotype has persisted among populations in northern Japan for some years.
The five ST8 SCCmec-IVa MRSA isolates found in the present study had identical sequences of PVL genes (haplotype R1) and arc and opp3 clusters in ACME (haplotype AC1) to those of USA300-0114 strains FPR3757 and TCH1516, and only a minor difference was found in the sarU promoter region. In addition, they also possessed the mobile genetic element-associated genes sek and seq (SaPI5), and chp and sak (WSA3usa), as found in the genome of the USA300-FPR3757 (Diep et al., 2006) . Therefore, the USA300 strains isolated in the present study may have a virtually identical genome to that of USA300-0114 strains, suggesting that only minimal genomic diversification has occurred during transmission from the USA to Japan. This finding may be supported by the high degree of genomic conservation among USA300 strains (USA300-0114) revealed by whole-genome and SNP analysis (Highlander et al., 2007; Kennedy et al., 2008) . However, the five USA300 MRSA isolates identified here were different in the presence of the plasmid-borne drug resistance genes tet(K) and aph(39)-IIIa, which are harboured by USA300-0114 strains FPR3757 and TCH1516, respectively (Diep et al., 2006; Shore et al., 2010) . In addition, these five isolates possessed both blaZ and msrA as in USA300, but lacked both ermC and mupA, unlike the FPR3757 and TCH1516 strains (Shore et al., 2010; Tenover et al., 2006) . Similar variation in distribution of drug resistance genes has been described for USA300 isolates from various countries (Monecke et al., 2007 . Therefore, it is possible that the genome of USA300 strains is highly stable, but that these isolates are subjected to genetic evolution, mostly through the acquisition or loss of plasmids carrying drug resistance genes during their transmission among the population.
It was notable in the present study that ACME-DII was detected in 15 PVL 2 MRSA (3.6 % among MRSA isolates) (Iwao et al., 2012a) , at a slightly higher rate than those reported in our previous studies under similar settings (1.1 %) and in a hospital-based study (1.2 %) in Hokkaido (Kawaguchiya et al., 2013) . These PVL 2 /ACME + MRSA isolates had mostly SCCmec-II (only one strain with SCCmec-V), and belonged to ST5 or ST764 (CC5), spat001, -t002 or -t3557, agr-II and coa-II, and showed multidrug resistance, harbouring various drug resistance genes. ST764 and spa-t001 are single-locus variants of ST5 and spa-t002, respectively, whilst spa type t3557 is a double-locus variant of spa-t001, indicating that the PVL 2 / ACME + MRSA are genetically closely related. However, these ACME-DII + MRSA exhibited genetic diversity in SCCmec types, spa types and SNPs in the arc cluster, and had different profiles of virulence-associated genes and drug resistance genes, suggesting more rapid and frequent transmission, or persistence for a longer time among humans, than ACME-I + ST8 MRSA, which is genetically highly homogeneous. ST5 SCCmec-II MRSA is one of the globally disseminated lineages referred to as the NY (New York)/Japan clone and has predominated in Japan as HA-MRSA (Chongtrakool et al., 2006; Oliveira et al., 2001) . The genetic characteristics of the NY/Japan clone, including the presence of virulence factors (Baba et al., 2002; Monecke et al., 2009) , were generally found in the three ACME + ST5 MRSA isolated in the present study, suggesting that these PVL 2 / ACME + ST5 isolates might have originated from the NY/ Japan clone, through acquisition of ACME-DII. In contrast, ST764 MRSA was revealed to be distinct from ST5 strains, and was referred to as a novel local variant of ST5 HA-MRSA by Takano and co-workers (Otsuka et al., 2012; Takano et al., 2013) . They identified and analysed seven ST764 SCCmec-II MRSA strains in Niigata prefecture, Japan (western coastal area in Honshu, the largest island). Whilst these strains belonged to spa-t002, agr-II and coa-II, like ST5 SCCmec-II MRSA, it was remarkable that these strains possessed ACME-DII and SaPInn54 harbouring the staphylococcal enterotoxin B gene (seb), and lacked PVL genes as well as tst, sec, sel and sep, unlike the NY/Japan clone. These characteristics were identical to those in the ST764 MRSA isolated in the present study, except for two isolates (one belonging to spa-t3557 and the other lacking seb), implying that the novel ST764 strains may be widely distributed in Japan.
In conclusion, the present study indicated the single clonality of ST8 PVL + /ACME-I + MRSA and the heterogeneity of CC5 PVL 2 /ACME-DII + MRSA including the novel ST764 MRSA in northern Japan. Continuous and systematic surveillance is considered to be necessary to take precautions against the spread of these emerging MRSA strains.
